It’s that time of year again, when more than 30,000 scientists specializing in blood cancers and other blood disorders, oncologists and hematologists, pharmaceutical and biotechnology company representatives, and cancer patient advocacy organizations gather in one place to learn about the latest progress in treatments and share new ideas.
This year, we’re in sunny Orlando for the 61st ASH (American Society of Hematology) Annual meeting and Exposition.
Today (Saturday) was the first official day, and there is already much to talk about, but first The Leukemia & Lymphoma Society (LLS) raised the curtain on Friday with several LLS-hosted programs.